• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Variant gene associated with endometriosis-related infertility

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
August 26, 2014
in Chronic Disease, Neurology
Reading Time: 3 mins read
Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients
Share on FacebookShare on Twitter

1. A normal variant of a gene responsible for cell-cell adhesionwas associated with primary infertility in northern Chinese women with ovarian endometriosis. 

Evidence Rating Level: 3 (Average)        

Study Rundown: Endometriosis, a disease characterized by the presence of endometrial tissue outside the uterine cavity, is seen in 5-10% of reproductive age women and an estimated 25-50% of women with infertility. While the association between endometriosis and infertility is widely accepted, the mechanism remains unclear. There is evidence to suggest that the same genetic mutations that allow the endometrium to implant outside the uterus may also lead to failure of the embryo to implant. E-cadherin is a protein that is important in cell-to-cell adhesion and some researchers believe that decreased expression of E-cadherin could be responsible for endometriosis. With this in mind, the authors of the present work set out to determine if certain normal genetic variations in the regulator regions of the E-cadherin gene may also be responsible for endometriosis-associated infertility.

Researchers found that one normal variant of E-cadherin was significantly associated with infertility in women with ovarian endometriosis. Additionally, they noted that eight of the 17 areas of genetic variation that were discovered to be potential targets were located in the 3’UTR region of the gene, an area important for gene expression. This is the first study to look at genetic variation in E-cadherin and endometriosis-related infertility. The generalizability of results are significantly limited by the homogenous nature of the patient population—all women in northern Chinese. Given the one-child family planning policy in China, researchers were unable to assess for a relationship with secondary infertility. Future prospective cohort studies comparing rates of infertility in endometriosis patients with and without this genetic variation would clarify the role of E-cadherin as a molecular marker for infertility in patients with ovarian endometriosis.

Click to read the study in Fertility & Sterility

Relevant Reading: Impaired down regulation of E-Cadherin and B-Catenin protein expression in endometrial epithelial cells in the mid-secretory endometrium of infertile patients with endometriosis

RELATED REPORTS

Surgery is associated with an increased quality of life in women with endometriosis

2 Minute Medicine Rewind August 10, 2026

Letrozole (Femara) improves sperm concentration in men with spermatogenic failure

In-Depth [case-control study]: Researchers compared patients with histologically confirmed diagnosis of ovarian endometriosis (n=589) with matched controls (n=589). Of those with ovarian endometriosis, 127 had primary infertility and 462 did not. Small Nucleotide Polymorphisms (SNPs) in the promoter region, exon, and 3’ UTR of E-cadherin were identified by direct sequencing and polymerase chain reaction (PCR) from blood samples of women with endometriosis, six of which were genotyped using a polymerase chain reaction/ligase detection reaction method.

Among women with endometriosis, those with infertility were more likely to be homozygous for the C-allele of the rs8049282 SNP (OR=2.54, p=0.001). Women with endometriosis and infertility were also more likely to have the CC genotype compared to women with a history of fertility (OR=2.70, p=0.002).

More from this author: Contained morcellation for benign gynecologic surgeries feasible, minimize surgical risk, Oocyte vitrification not associated with adverse obstetric or perinatal outcomes, IUD contraception equally safe in teenagers as in older women, No-cost contraception reduces unintended pregnancy rates, 20% lifetime risk of pelvic floor surgery in women

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: endometriosisinfertility
Previous Post

Growth factor embedded film promotes robust bone repair

Next Post

Dermatological consultation in outpatients improves diagnosis of cellulitis

RelatedReports

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Chronic Disease

Surgery is associated with an increased quality of life in women with endometriosis

August 11, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Challenges and feasibility of fertility preservation in feminizing transgender youth
Chronic Disease

Letrozole (Femara) improves sperm concentration in men with spermatogenic failure

July 13, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

Children conceived through infertility treatments may have similar growth compared to naturally conceived children

June 11, 2026
Next Post
Dermatological consultation in outpatients improves diagnosis of cellulitis

Dermatological consultation in outpatients improves diagnosis of cellulitis

Ultrasound, flow reserve guided coronary interventions provide minimal benefit

Coronary angiography in asymptomatic patients may lead to inappropriate percutaneous interventions

Deep brain stimulation may be safe for older Parkinson patients

Deep brain stimulation may be safe for older Parkinson patients

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality
  • Alcohol use declines but remains above pre-pandemic levels
  • High maternal egg-peanut intake not associated with reduced infant allergy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.